The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | Loren Stefan | Insider | Grant(A) | 15K | — | $0 |
| Jul 7, 2026 | Chanan-Khan Asher | Director | Grant(A) | 25K | — | $0 |
| Jul 7, 2026 | Caruso James V | President & CEO, Director | Grant(A) | 250K | — | $0 |
| Jul 7, 2026 | Gu Andrew | Director | Grant(A) | 25K | — | $0 |
| Jul 7, 2026 | Longcor Jarrod | Chief Operating Officer | Grant(A) | 118K | — | $0 |
| Jul 7, 2026 | Swirsky Douglas J | Director | Grant(A) | 38K | — | $0 |
| Jul 7, 2026 | Neis John | Director | Grant(A) | 25K | — | $0 |
| Jul 7, 2026 | Kolean Chad J | CFO | Grant(A) | 92K | — | $0 |
| Jul 7, 2026 | Driscoll Frederick W | Director | Grant(A) | 25K | — | $0 |
| May 7, 2026 | Caruso James V | Chief Executive Officer, Director | Buy(P) | 9K | $2.88 | $25K |
| May 7, 2026 | Caruso James V | Chief Executive Officer, Director | Buy(P) | 26K | $0.01 | $260 |
| May 7, 2026 | Longcor Jarrod | Chief Operating Officer | Buy(P) | 9K | $2.88 | $25K |
| May 7, 2026 | Longcor Jarrod | Chief Operating Officer | Buy(P) | 26K | $0.01 | $260 |
| Dec 12, 2025 | Neis John | Director | Sell(S) | 198 | $3.70 | $733 |
| Jul 2, 2025 | Kolean Chad J | Chief Financial Officer | Buy(P) | 5K | $4.99 | $25K |
| Jul 2, 2025 | Kolean Chad J | Chief Financial Officer | Buy(P) | 5K | $0.01 | $50 |
| Jul 2, 2025 | Longcor Jarrod | Chief Operating Officer | Buy(P) | 10K | $4.99 | $50K |
| Jul 2, 2025 | Longcor Jarrod | Chief Operating Officer | Buy(P) | 10K | $0.01 | $100 |
| Jul 2, 2025 | Caruso James V | Chief Executive Officer, Director | Buy(P) | 10K | $4.99 | $50K |
| Jul 2, 2025 | Caruso James V | Chief Executive Officer, Director | Buy(P) | 10K | $0.01 | $100 |
| Feb 14, 2025 | Caruso James V | President and CEO, Director | Grant(A) | 900K | — | $0 |
| Feb 14, 2025 | Chanan-Khan Asher | Director | Grant(A) | 60K | — | $0 |
| Feb 14, 2025 | Driscoll Frederick W | Director | Grant(A) | 60K | — | $0 |
| Feb 14, 2025 | Kolean Chad J | Chief Financial Officer | Grant(A) | 290K | — | $0 |
| Feb 14, 2025 | Longcor Jarrod | Chief Operating Officer | Grant(A) | 500K | — | $0 |
| Feb 14, 2025 | Loren Stefan | Director | Grant(A) | 60K | — | $0 |
| Feb 14, 2025 | Neis John | Director | Grant(A) | 60K | — | $0 |
| Feb 14, 2025 | Swirsky Douglas J | Director | Grant(A) | 90K | — | $0 |
| Jan 10, 2025 | Longcor Jarrod | Chief Operating Officer | Buy(P) | 30K | $0.28 | $8K |
| Jun 14, 2024 | Chanan-Khan Asher | Director | Grant(A) | 60K | — | $0 |
| Jun 14, 2024 | Driscoll Frederick W | Director | Grant(A) | 60K | — | $0 |
| Jun 14, 2024 | Neis John | Director | Grant(A) | 60K | — | $0 |
| Jun 14, 2024 | Swirsky Douglas J | Director | Grant(A) | 90K | — | $0 |
| Jun 14, 2024 | Loren Stefan | Director | Grant(A) | 60K | — | $0 |
| Jun 14, 2024 | Lea Darrell Shane | Chief Commercial Officer | Grant(A) | 260K | — | $0 |
| Jun 14, 2024 | Shustov Andrei | Senior Vice President, Medical | Grant(A) | 260K | — | $0 |
| Jun 14, 2024 | Kolean Chad J | Chief Financial Officer | Grant(A) | 290K | — | $0 |
| Jun 14, 2024 | Caruso James V | President and CEO, Director | Grant(A) | 900K | — | $0 |
| Jun 14, 2024 | Longcor Jarrod | Chief Operating Officer | Grant(A) | 500K | — | $0 |
| Dec 8, 2023 | Caruso James V | President and CEO, Director | Grant(A) | 41K | — | $0 |
| Dec 8, 2023 | Longcor Jarrod | Chief Operating Officer | Grant(A) | 43K | — | $0 |
| Dec 8, 2023 | Shustov Andrei | Senior Vice President, Medical | Grant(A) | 48K | — | $0 |
| Dec 8, 2023 | Kolean Chad J | Chief Financial Officer | Grant(A) | 43K | — | $0 |
| Dec 8, 2023 | Lea Darrell Shane | Chief Commercial Officer | Grant(A) | 40K | — | $0 |
| Jun 28, 2023 | Chanan-Khan Asher | Director | Grant(A) | 25K | — | $0 |
| Jun 28, 2023 | Driscoll Frederick W | Director | Grant(A) | 25K | — | $0 |
| Jun 28, 2023 | Loren Stefan | Director | Grant(A) | 25K | — | $0 |
| Jun 28, 2023 | Neis John | Director | Grant(A) | 25K | — | $0 |
| Jun 28, 2023 | Swirsky Douglas J | Director | Grant(A) | 38K | — | $0 |
| Jun 23, 2023 | Caruso James V | President and CEO, Director | Grant(A) | 261K | — | $0 |
| Jun 23, 2023 | Longcor Jarrod | Chief Operating Officer | Grant(A) | 144K | — | $0 |
| Jun 23, 2023 | Kolean Chad J | Chief Financial Officer | Grant(A) | 104K | — | $0 |
| Jun 23, 2023 | Lea Darrell Shane | Chief Commercial Officer | Grant(A) | 100K | — | $0 |
| Feb 15, 2023 | Shustov Andrei | Senior Vice President, Medical | Grant(A) | 100K | — | $0 |
| Jan 17, 2023 | Kolean Chad J | Chief Financial Officer | Grant(A) | 104K | — | $0 |
| Jan 17, 2023 | Caruso James V | President and CEO, Director | Grant(A) | 261K | — | $0 |
| Jan 17, 2023 | Longcor Jarrod | Chief Operating Officer | Grant(A) | 144K | — | $0 |
| Nov 21, 2022 | Lea Darrell Shane | Chief Commercial Officer | Grant(A) | 100K | — | $0 |
| Jun 24, 2022 | Chanan-Khan Asher | Director | Grant(A) | 8K | — | $0 |
| Jun 24, 2022 | Driscoll Frederick W | Director | Grant(A) | 8K | — | $0 |
| Jun 24, 2022 | Loren Stefan | Director | Grant(A) | 8K | — | $0 |
| Jun 24, 2022 | Neis John | Director | Grant(A) | 8K | — | $0 |
| Jun 24, 2022 | Swirsky Douglas J | Director | Grant(A) | 12K | — | $0 |
| Feb 22, 2022 | Kolean Chad J | Chief Financial Officer | Grant(A) | 150K | — | $0 |
| Jan 25, 2022 | Caruso James V | President and CEO, Director | Grant(A) | 1.4M | — | $0 |
| Jan 25, 2022 | Elefant Dov | Chief Financial Officer | Grant(A) | 422K | — | $0 |
| Jan 25, 2022 | Longcor Jarrod | Chief Business Officer | Grant(A) | 475K | — | $0 |
| Sep 14, 2021 | Swirsky Douglas J | Director | Buy(P) | 25K | $1.04 | $26K |
| Sep 3, 2021 | Driscoll Frederick W | Director | Buy(P) | 19K | $1.04 | $20K |
| Jun 30, 2021 | Chanan-Khan Asher | Director | Grant(A) | 78K | — | $0 |
| Jun 30, 2021 | Driscoll Frederick W | Director | Grant(A) | 78K | — | $0 |
| Jun 30, 2021 | Loren Stefan | Director | Grant(A) | 78K | — | $0 |
| Jun 30, 2021 | Neis John | Director | Grant(A) | 78K | — | $0 |
| Jun 30, 2021 | Swirsky Douglas J | Director | Grant(A) | 117K | — | $0 |
| Mar 18, 2021 | Neis John | Director | Sell(S) | 23K | $0.25 | $6K |
| Mar 17, 2021 | Neis John | Director | Sell(S) | 59K | $0.28 | $16K |
| Mar 16, 2021 | Neis John | Director | Sell(S) | 101K | $0.31 | $31K |
| Mar 15, 2021 | Neis John | Director | Sell(S) | 11K | $0.27 | $3K |
| Mar 12, 2021 | Neis John | Director | Sell(S) | 41K | $0.27 | $11K |
| Mar 4, 2021 | Caruso James V | President and CEO, Director | Buy(P) | 5K | $1.70 | $9K |
| Mar 4, 2021 | Caruso James V | President and CEO, Director | Grant(A) | 1.6M | — | $0 |
| Mar 4, 2021 | Caruso James V | President and CEO, Director | Sell(S) | 47K | $0.19 | $9K |
| Mar 4, 2021 | Friend John E. II | Chief Medical Officer | Grant(A) | 330K | — | $0 |
| Mar 4, 2021 | Longcor Jarrod | Chief Business Officer | Grant(A) | 450K | — | $0 |
| Mar 4, 2021 | Elefant Dov | Chief Financial Officer | Grant(A) | 430K | — | $0 |
| Dec 28, 2020 | Elefant Dov | Chief Financial Officer | Buy(P) | 7K | $1.35 | $10K |
| Dec 28, 2020 | Longcor Jarrod | Chief Business Officer | Buy(P) | 30K | $1.35 | $40K |
| Dec 28, 2020 | Caruso James V | President and CEO, Director | Buy(P) | 37K | $1.35 | $50K |
| Jul 1, 2020 | Friend John E. II | VP, Chief Medical Officer | Grant(A) | 100K | — | $0 |
| Jun 24, 2020 | Driscoll Frederick W | Director | Grant(A) | 50K | — | $0 |
| Jun 24, 2020 | Swirsky Douglas J | Director | Grant(A) | 80K | — | $0 |
| Jun 24, 2020 | Hill Stephen A | Director | Grant(A) | 50K | — | $0 |
| Jun 24, 2020 | Neis John | Director | Grant(A) | 50K | — | $0 |
| Jun 24, 2020 | Loren Stefan | Director | Grant(A) | 50K | — | $0 |
| Jun 5, 2020 | Caruso James V | President and CEO, Director | Buy(P) | 22K | $1.15 | $25K |
| Jun 5, 2020 | Caruso James V | President and CEO, Director | Buy(P) | 11K | $0.01 | $109 |
| Jun 5, 2020 | Longcor Jarrod | Chief Business Officer | Buy(P) | 65K | $1.15 | $75K |
| Jun 5, 2020 | Longcor Jarrod | Chief Business Officer | Buy(P) | 33K | $0.01 | $326 |
| Jun 5, 2020 | Elefant Dov | Chief Financial Officer | Buy(P) | 4K | $1.15 | $5K |
| Jun 5, 2020 | Elefant Dov | Chief Financial Officer | Buy(P) | 2K | $0.01 | $22 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Cellectar Biosciences, Inc., SEC CIK 0001279704. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under CLRB and shows every filing by that issuer.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-05. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for CLRB